Organovo Holdings, Inc. (ONVO): Price and Financial Metrics


Organovo Holdings, Inc. (ONVO): $1.77

-0.01 (-0.28%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ONVO Stock Price Chart Interactive Chart >

Price chart for ONVO

ONVO Price/Volume Stats

Current price $1.77 52-week high $9.56
Prev. close $1.78 52-week low $1.71
Day low $1.71 Volume 15,900
Day high $1.80 Avg. volume 38,090
50-day MA $2.41 Dividend yield N/A
200-day MA $4.02 Market Cap 15.42M

Organovo Holdings, Inc. (ONVO) Company Bio


Organovo Holdings, Inc. focuses on developing and commercializing functional human tissues that could be employed in drug discovery and development, biological research, and as therapeutic implants for the treatment of damaged or degenerating tissues and organs. The company was founded in 2007 and is based in San Diego, California.


ONVO Latest News Stream


Event/Time News Detail
Loading, please wait...

ONVO Latest Social Stream


Loading social stream, please wait...

View Full ONVO Social Stream

Latest ONVO News From Around the Web

Below are the latest news stories about Organovo Holdings Inc that investors may wish to consider to help them evaluate ONVO as an investment opportunity.

Why Organovo Holdings, Inc. Stock Soared 49.7% This Week

The company''s licensing agreement with a Swedish company means an infusion of some much-needed cash for Organovo.

The Motley Fool | March 3, 2022

UPDATE -- Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents

SAN DIEGO, March 01, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), and BICO (OTCPK: CLLKF, Nasdaq Stockholm: BICO.ST) announced they have reached agreement on a broad license for BICO and its affiliate companies to Organovo’s foundational patent portfolio in 3D bioprinting. Founded in 2016, BICO (formerly Cellink) is the leading bio convergence company in the world. Cellink continues to operate as a wholly owned division of BICO. Organovo exclusively licensed early bioprinting

Yahoo | March 1, 2022

Organovo and BICO (CELLINK) Reach Licensing Agreement on Bioprinting Patents

SAN DIEGO, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ: ONVO ), and BICO today announced they have reached agreement on a broad license for BICO and its affiliate companies to Organovo''s foundational patent portfolio in 3D bioprinting. Founded in 2016, BICO (formerly Cellink) is the leading bio convergence company in the world. Cellink continues to operate as a wholly owned division of BICO. Organovo exclusively licensed early bioprinting work by Gabor Forgacs, its scientific founder, and Thomas Boland of Clemson, both bioprinting pioneers. After its founding, the company did early innovation in the 3D bioprinter space and obtained a further broad set of patents that provide foundational claims in the bioprinting space. In order to broaden the impact of the techno...

Benzinga | February 23, 2022

Organovo Welcomes New Sr. Vice President of Strategy and Business Development

SAN DIEGO , Feb. 18, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO), a three-dimensional biology company focused on delivering scientific and medical breakthroughs using 3D bioprinting technology, today announced the hiring of Curtis Tyree , PhD, as Sr.

Organovo Holdings | February 18, 2022

Organovo Holdings, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

SAN DIEGO, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo”), today announced that it has granted a stock option to purchase 50,000 shares of common stock to one new employee. The stock option was granted pursuant to the Organovo Holdings, Inc. 2021 Inducement Equity Incentive Plan and granted as an inducement material to the new employee entering into employment with Organovo in accordance with Nasdaq Listing Rule 5635(c)(4). The stock option has an exercise

Yahoo | February 18, 2022

Read More 'ONVO' Stories Here

ONVO Price Returns

1-mo -27.13%
3-mo -52.29%
6-mo -51.24%
1-year -80.16%
3-year -81.93%
5-year -96.63%
YTD -51.24%
2021 -70.49%
2020 72.90%
2019 -62.95%
2018 -28.36%
2017 -60.47%

Continue Researching ONVO

Here are a few links from around the web to help you further your research on Organovo Holdings Inc's stock as an investment opportunity:

Organovo Holdings Inc (ONVO) Stock Price | Nasdaq
Organovo Holdings Inc (ONVO) Stock Quote, History and News - Yahoo Finance
Organovo Holdings Inc (ONVO) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.4646 seconds.